Patents by Inventor Daniel Scott Auld

Daniel Scott Auld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10874685
    Abstract: The present disclosure provides a novel method for treating pancreatic cancer and pancreatitis in which a combination of a dopamine receptor antagonist (pimozide, haloperidol, and/or L-741,626), 2-deoxy-D-glucose and atorvastatin are used, optionally in combination with gemcitabine.
    Type: Grant
    Filed: August 12, 2019
    Date of Patent: December 29, 2020
    Assignees: THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY, DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS
    Inventors: Pouria Jandaghi, Yasser Riaz Alhosseini, Daniel Scott Auld, Veena Sangwan
  • Publication number: 20200030356
    Abstract: The present disclosure provides a novel method for treating pancreatic cancer and pancreatitis. The disclosure pertains to antagonists of dopamine receptors, that when combined with a glycolysis inhibitor, and a cholesterol lowering agent inhibit the growth of pancreatic cells.
    Type: Application
    Filed: August 12, 2019
    Publication date: January 30, 2020
    Inventors: Pouria JANDAGHI, Yasser RIAZ ALHOSSEINI, Daniel Scott AULD, Veena SANGWAN
  • Patent number: 7579468
    Abstract: Disclosed are compositions which modulate the interaction with nerve growth factor and precursors thereof with neurotrophic receptors. Also disclosed are methods of using the compositions of the invention, including methods of administration.
    Type: Grant
    Filed: September 14, 2006
    Date of Patent: August 25, 2009
    Assignee: PainCeptor Pharma Corporation
    Inventors: Kazimierz Babinski, Rahul Vohra, Xilin Cui, Daniel Scott Auld, Nachhattarpal Gill